Klor-con and Congo-crimean haemorrhagic fever - a phase IV clinical study of FDA data

Summary:

Congo-crimean haemorrhagic fever is reported as a side effect among people who take Klor-con (potassium chloride), especially for people who are male, 60+ old, also take Haloperidol, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Congo-crimean haemorrhagic fever when taking Klor-con. It is created by eHealthMe based on reports of 27,036 people who have side effects when taking Klor-con from the FDA, and is updated regularly.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

What is Congo-crimean haemorrhagic fever?

Congo-crimean haemorrhagic fever (tick-borne viral disease with bleeding) is found to be associated with 54 drugs and 9 conditions by eHealthMe. Check the latest studies of Congo-crimean haemorrhagic fever.

On Jul, 05, 2026

27,036 people reported to have side effects when taking Klor-con.
Among them, 13 people (0.05%) have Congo-crimean haemorrhagic fever.

Could Klor-con cause Congo-crimean haemorrhagic fever?

Among these 13 people:

What is the gender of people who have Congo-crimean haemorrhagic fever when taking Klor-con? *

female: 0.0 %
male: 100 %

What is the age of people who have Congo-crimean haemorrhagic fever when taking Klor-con? *

What are other drugs people take besides Klor-con? *

What are other side effects people have besides Congo-crimean haemorrhagic fever? *

Weakness: 13 people, 100.00%
Gallstones (stone formation by bile component): 13 people, 100.00%
Ejection Fraction Decreased (systolic heart failure): 13 people, 100.00%
Electrocardiogram Qt Prolonged: 13 people, 100.00%
Electrocardiogram St Segment Depression: 13 people, 100.00%
Electrocardiogram T Wave Abnormal: 13 people, 100.00%
Encephalopathy (functioning of the brain is affected by some agent or condition): 13 people, 100.00%
Enlarged Heart: 13 people, 100.00%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 13 people, 100.00%
Fever: 13 people, 100.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 13 people, 100.00%
Procedural Pain: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con and have Congo-crimean haemorrhagic fever?

- Check whether Congo-crimean haemorrhagic fever is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Klor-con:

Klor-con (27,547 reports)

Browse all side effects of Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Congo-crimean haemorrhagic fever:

Congo-crimean haemorrhagic fever (54 drugs)

Browse all the conditions that are associated with Congo-crimean haemorrhagic fever:

Congo-crimean haemorrhagic fever (9 conditions)

Related publications that referenced our studies

Oflaz MB, Kucukdurmaz Z, Guven AS, Karapinar H, Kaya A, Sancakdar E, Deveci K, Gul I, Erdem A, Cevit O, Icagasioglu FD, "Bradycardia seen in children with Crimean-Congo hemorrhagic fever", Vector-Borne and Zoonotic Diseases, 2013 Nov .
Oflaz MB, Kucukdurmaz Z, Guven AS, Karapinar H, Kaya A, Sancakdar E, Deveci K, Gul I, Erdem A, Cevit O, Icagasioglu FD, "Bradycardia seen in children with Crimean-Congo hemorrhagic fever", Vector-Borne and Zoonotic Diseases, 2013 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride (the active ingredients of Klor-con) and Klor-con (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.